Search

Your search keyword '"Milicic, D."' showing total 426 results

Search Constraints

Start Over You searched for: Author "Milicic, D." Remove constraint Author: "Milicic, D."
426 results on '"Milicic, D."'

Search Results

4. Lower Platelet Count Following Induction with Antithymocyte Globulin is Associated with a Lower Incidence of Cardiac Allograft Vasculopathy

5. Intravenous angiotensin II as an add-on to standard of care vasopressors in patients with refractory shock on mechanical circulatory support: a single centre retrospective case series

6. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

7. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

8. Predominance of a rare transthyretin mutation (p.Asp38Glu) in patients with hATTR cardiomyopathy: initial data from the Croatian Transthyretin Cardiac Amyloidosis Registry (CroATTR)

9. Incidence of restenosis after drug-coated balloon percutaneous coronary intervention in patients with diabetes mellitus - a single-centre experience

13. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

15. Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

16. Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

18. Heart failure in patients is associated with downregulation of mitochondrial quality control genes.

20. The case against premature treatment of heart failure patients with implantable cardioverter-defibrillators: results from an institutional registry

21. Relation between sex and mortality after myocardial infarction in high-income and middle-income European countries

22. Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

23. Prevalence of standard modifiable cardiovascular risk factors in patients with ST segment elevation myocardial infarction and its relation with outcomes

24. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

25. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

26. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

27. COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

28. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

29. Is early percutaneous coronary intervention safe in patients ACS and cancer?

30. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

33. Cardiac emergencies following earthquake

34. Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

35. Impact analysis of heart failure across European countries: an ESC-HFA position paper

36. Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome

37. Hybrid Dorsal Preservation Rhinoplasty: How We Do It

39. Acute heart failure: a mechanism underscoring sex differences in outcomes following acute coronary syndromes

41. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

42. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

43. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

44. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

45. IS A FAMILY HISTORY OF CORONARY HEART DISEASE AN INDEPENDENT CARDIOVASCULAR RISK FACTOR?

47. Statins for primary prevention among elderly men and women

48. Comprehensive assessment of myocardial remodeling in ischemic heart disease by synchrotron propagation based X-ray phase contrast imaging

49. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology

50. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)

Catalog

Books, media, physical & digital resources